Human |
Escherichia coli and Staphylococcus |
Induction of DNA double-strand break and genomic instability in vitro |
[14] |
Human |
Clostridiales |
Inhibition of tumor growth by producing the metabolite trimethylamine N-oxide (TMAO) that activates CD8+ T cells- mediated antitumor-immunity |
[53] |
Human |
Fusobacterium nucleatum
|
Breast tumor progression and metastases by fap-2 dependent binding of the bacterium to breast cancer tissue Gal-GalNac |
[68] |
Mice |
Staphylococcus, Lactobacillus and Streptococcus |
Breast tumor lung metastases by modulating the stress response and influencing cancer cell viability, altering the cell cytoskeleton |
[15] |
Mice |
Staphylococcus epidermidis
|
Increased T regulatory cell infiltration in the tumor and complement pathway activation in vivo, and increased pro-tumoral M2 macrophages phenotype in vitro |
[16] |
Mice |
Micrococcus luteus
|
Reduction of mammary tumor growth in vivo, and increased anti-tumoral M1 macrophage phenotype in vitro |
[16] |
Mice |
Bacteroides fragilis
|
Breast tumor progression and metastasis through the secretion of the B. fragilis toxin (BFT) |
[65] |